MyAbilities Technologies, a company involved in smart health technology and workplace safety, has launched what is claimed to be the world's first online Digital Job Analysis database, JobXweb.com, it was reported yesterday.
The free database offers users access to more than 50,000 job titles, each with unique industry Digital Job Profiles including comprehensive analysis of the psychosocial, cognitive and physical demands in addition to a comprehensive job description. Each Digital Job Profile includes the essential demands of that job, whether they are physical, cognitive or psychosocial. Digital Job Profiles are shared with various stakeholders to support decisions leveraging the exact same set of data in a standardised, visual way to understand all the demands of the job.
Dr Michael Sonne, vice president, innovations and research at MyAbilities Technologies, said, 'Organisations can quickly search through a simple and free database to conduct a thorough review of the demands of thousands of jobs across all industries. We believe JobXweb.com is the first of its kind to offer easy access to a standardised analysis of thousands of jobs, and to present the information in a clear, shareable way.'
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA